WhiteOak Capital Mutual Fund
← All mutual funds

WhiteOak Capital Pharma and Healthcare Fund - Direct Plan - Growth Option

WhiteOak Capital Mutual Fund · Sectoral/Thematic · Direct · Growth

NAV · as of 11/09/2026

17.76

1D

-0.45%

1Y

+22.68%

Key stats

Expense ratio
1.16%
AUM
₹824.80 Cr
Launched
06/02/2024
Fund manager
Piyush Baranwal; Ramesh Mantri; Trupti Agrawal; Dheeresh Pathak; Ashish Agrawal
Portfolio turnover
0.02%
Risk
Very High Risk
Min lump-sum
₹500
Min SIP
₹100/mo
Fresh lump-sum
Accepted
Fresh SIP
Accepted

NAV history

WhiteOak Capital Pharma and Healthcare Fund - Direct Plan - Growth Option

13/08/2026 to 11/09/2026

O - H - L -

17.8517.4513/08/202611/09/2026
1W+1.18%
1M+0.74%
3M+11.34%
6M+26.52%
1Y+22.68%
MAX+76.27%

Top holdings

70 disclosed
  • 1.

    Sun Pharmaceuticals Industries Ltd

    Healthcare

    8.53%
  • 2.

    Torrent Pharmaceuticals Ltd

    Healthcare

    7.81%
  • 3.

    Laurus Labs Ltd

    Healthcare

    4.94%
  • 4.

    Apollo Hospitals Enterprise Ltd

    Healthcare

    4.78%
  • 5.

    Cash Offset For Derivatives

    4.74%
  • 6.

    Divi's Laboratories Ltd

    Healthcare

    3.86%
  • 7.

    Max Healthcare Institute Ltd Ordinary Shares

    Healthcare

    3.76%
  • 8.

    Cipla Ltd

    Healthcare

    3.72%
  • 9.

    Sai Life Sciences Ltd

    Healthcare

    3.18%
  • 10.

    Zydus Lifesciences Ltd

    Healthcare

    2.94%
  • 11.

    Neuland Laboratories Ltd

    Healthcare

    2.87%
  • 12.

    Dr. Lal PathLabs Ltd

    Healthcare

    2.53%
  • 13.

    Clearing Corporation Of India Ltd

    2.51%
  • 14.

    Corona Remedies Ltd

    Healthcare

    2.44%
  • 15.

    Aurobindo Pharma Ltd

    Healthcare

    2.42%
  • 16.

    Krishna Institute of Medical Sciences Ltd

    Healthcare

    2.34%
  • 17.

    Future on Cipla Ltd

    2.27%
  • 18.

    Fortis Healthcare Ltd

    Healthcare

    2.20%
  • 19.

    Thyrocare Technologies Ltd

    Healthcare

    2.20%
  • 20.

    Narayana Hrudayalaya Ltd

    Healthcare

    1.82%
  • 21.

    Ajanta Pharma Ltd

    Healthcare

    1.81%
  • 22.

    Procter & Gamble Health Ltd

    Healthcare

    1.70%
  • 23.

    Aurobindo Pharma Limited

    1.66%
  • 24.

    Rainbow Childrens Medicare Ltd

    Healthcare

    1.61%
  • 25.

    Granules India Ltd

    Healthcare

    1.56%
  • 26.

    Vijaya Diagnostic Centre Ltd

    Healthcare

    1.53%
  • 27.

    Aether Industries Ltd

    Basic Materials

    1.47%
  • 28.

    Anthem Biosciences Ltd

    Healthcare

    1.47%
  • 29.

    Navin Fluorine International Ltd

    Basic Materials

    1.46%
  • 30.

    Acutaas Chemicals Ltd

    Basic Materials

    1.44%
  • 31.

    Shaily Engineering Plastics Ltd

    Basic Materials

    1.39%
  • 32.

    06/08/2026 Maturing 182 DTB

    1.21%
  • 33.

    Global Health Ltd

    Healthcare

    1.18%
  • 34.

    OneSource Specialty Pharma Ltd

    Healthcare

    1.18%
  • 35.

    Ipca Laboratories Ltd

    Healthcare

    1.12%
  • 36.

    Innova Captab Ltd

    Healthcare

    1.10%
  • 37.

    Jupiter Life Line Hospitals Ltd

    Healthcare

    1.07%
  • 38.

    Pfizer Ltd

    Healthcare

    1.03%
  • 39.

    Manipal Health Enterprises Ltd

    Healthcare

    0.97%
  • 40.

    Kovai Medical Center & Hospital Ltd

    Healthcare

    0.95%
  • 41.

    Poly Medicure Ltd

    Healthcare

    0.91%
  • 42.

    Gland Pharma Ltd

    Healthcare

    0.91%
  • 43.

    Senores Pharmaceuticals Ltd

    Healthcare

    0.85%
  • 44.

    Aarti Pharmalabs Ltd

    Healthcare

    0.85%
  • 45.

    Vimta Labs Ltd

    Healthcare

    0.76%
  • 46.

    Nephrocare Health Services Ltd

    Healthcare

    0.67%
  • 47.

    Supriya Lifescience Ltd

    Healthcare

    0.60%
  • 48.

    Biocon Ltd

    Healthcare

    0.54%
  • 49.

    India (Republic of)

    0.48%
  • 50.

    India (Republic of)

    0.48%
  • 51.

    Max Healthcare Institute Limited

    0.48%
  • 52.

    Tatva Chintan Pharma Chem Ltd

    Basic Materials

    0.47%
  • 53.

    Zota Health Care Ltd

    Healthcare

    0.45%
  • 54.

    India (Republic of)

    0.41%
  • 55.

    Sudeep Pharma Ltd

    Healthcare

    0.37%
  • 56.

    India (Republic of)

    0.36%
  • 57.

    Net Receivables / (Payables)

    0.36%
  • 58.

    Orchid Pharma Ltd

    Healthcare

    0.27%
  • 59.

    Apollo Hospitals Enterprise Limited

    0.26%
  • 60.

    Laxmi Dental Ltd

    Healthcare

    0.23%
  • 61.

    Cohance Lifesciences Ltd

    Healthcare

    0.21%
  • 62.

    India (Republic of)

    0.19%
  • 63.

    India (Republic of)

    0.14%
  • 64.

    India (Republic of)

    0.10%
  • 65.

    Sun Pharmaceutical Industries Limited

    0.08%
  • 66.

    India (Republic of)

    -
  • 67.

    Aster DM Quality Care Ltd Ordinary Shares

    -
  • 68.

    Mankind Pharma Ltd

    -
  • 69.

    Glenmark Pharmaceuticals Ltd

    -
  • 70.

    Strides Pharma Science Ltd

    -

Sector allocation

  • Healthcare88.22%
  • Unclassified15.73%
  • Basic Materials6.24%

Comparable peers

  • Whiteoak Capital Pharma & Healthcare Growth Direct Plan

    Whiteoak Capital Pharma & Healthcare (G) · ₹824.80 Cr AUM

    1Y+23.55%
    3Y0.00%
    -

  • SBI Healthcare Opportunities Growth Direct Plan

    SBI Healthcare Opportunities (G) · ₹5.80 K Cr AUM

    1Y+22.13%
    3Y+24.61%
    -

  • Mirae Asset Healthcare Growth Direct Plan

    Mirae Healthcare (G) · ₹3.44 K Cr AUM

    1Y+20.35%
    3Y+23.20%
    -

  • UTI Healthcare Growth Direct Plan

    UTI Healthcare (G) · ₹1.44 K Cr AUM

    1Y+17.28%
    3Y+24.42%
    -

  • HDFC Transportation & Logistics Growth Direct Plan

    HDFC Transportation & Logistics (G) · ₹1.96 K Cr AUM

    1Y+9.79%
    3Y+25.46%
    -

Investment objective

The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. However, there can be no assurance that the investment objective of the Scheme will be realized.

Scheme details

Scheme code
152349
Fund house
WhiteOak Capital Mutual Fund
Category
Open Ended
Type
Equity Schemes
Sub-category
Sectoral/Thematic
Plan
Direct
Return type
Growth
ISIN (Growth)
INF03VN01886
ISIN (Div. Reinvest)
-
Tradable on exchange
No

Kuvera page